Trius Therapeutics, Inc. (TSRX) Message Board

CBIS wouldn't have spun off their profitable cosmetic division afiliate of GWPRF, now trading as XCHC if there wasn't some sound science behind the company's research. It's hard to pump your research science when you work with an illegal substance but CBIS wanted to concentrate on their potential pharma applications, not on retail-by product cosmeticss which may have limited upside downstream as competition moves in. I use hemp products & don't use recreational MJ, but believe it has many legit medical applications that have not been fully developed. We need new antibiotic treatments that are not the conventional ones currently in use. Current antibiotics that pharma is promoting develope resistant MRSA strains and quickly become ineffective to these new superbugs.
#$%$ has long been known to have antibacterial properties and was studied in the 1950s as a treatment for tuberculosis and other diseases. But research into using #$%$ as an antibiotic has been limited by poor knowledge of the plant's active ingredients and by the controversy surrounding its illegal use as a recreational drug.
Substances harvested from #$%$ plants could soon outshine conventional antibiotics in the escalating battle against drug-resistant bacteria. The compounds, called cannabinoids, appear to be unaffected by the mechanism that superbugs like MRSA use to evade existing antibiotics. Scientists from Italy and the United Kingdom, who published their research in the Journal of Natural Products, say that #$%$-based topical creams could also be developed to treat persistent skin infections.
STAY TUNNED